3-Chloro-6-(pyridin-3-yl)pyridazine → HCID 57654477, compound
Reaction equation
[Cl:1][C:2]1[CH:11]=[CH:10][C:9]2[C:4](=[CH:5][CH:6]=[C:7]([CH2:12][C:13]([NH:15][NH2:16])=O)[CH:8]=2)[N:3]=1.Cl[C:18]1[N:19]=[N:20][C:21]([C:24]2[CH:25]=[N:26][CH:27]=[CH:28][CH:29]=2)=[CH:22][CH:23]=1>C(O)CCC>[Cl:1][C:2]1[CH:11]=[CH:10][C:9]2[C:4](=[CH:5][CH:6]=[C:7]([CH2:12][C:13]3[N:19]4[N:20]=[C:21]([C:24]5[CH:25]=[N:26][CH:27]=[CH:28][CH:29]=5)[CH:22]=[CH:23][C:18]4=[N:16][N:15]=3)[CH:8]=2)[N:3]=1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
(2-Chloro-quinolin-6-yl)-acetic acid hydrazide (0.030 g, 0.127 mmol) and 3-chloro-6-pyridin-3-yl-pyridazine (0.024 g, 0.127 mmol) were heated to reflux in butanol (0.5 mL) for several hours. The reaction was cooled to room temperature and filtered. The filtrate was purified via reverse phase HPLC on a C18 column eluting with acetonitrile in water (0.1% TFA) to give 0.017 g (35%) of 2-chloro-6-(6-pyridin-3-yl-[1,2,4]triazolo[4,3-b]pyridazin-3-ylmethyl)-quinoline.
Workup
- filtrationfiltered
- customThe filtrate was purified via reverse phase HPLC on a C18 column
- washeluting with acetonitrile in water (0.1% TFA)
Sources & evidence
- ORD record
- ord-cc6081f4170e4579bb1bd24c7d16df71
- Source dataset
- uspto-grants-2011_10
- Patent number
- US08030305B2
Reaction notes
Loading…